EMA SAYS EU PHARMA SECTOR MARKET APPROVALS INDICATE INCREASED INNOVATION
February 1st, 2014
THE EUROPEAN Union’s (EU) pharmaceutical sector is becoming more innovative according to new market approval statistics, that showed the number of medicines containing a new active substance in 2013 was 38; compared to 35 in 2012; 25 in 2011; and 15 in 2010. EMA said the 2013 figure was “quite high”, adding its committee for medicinal products for human use (CHMP) recommended market approval for 81 medicines last year, compared with 57 in 2012. The number of generics approved was stable compared with 2012, “but generally decreasing over the last few ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.